Literature DB >> 28741567

Metastasis: Circulating Tumor Cells in Small Cell Lung Cancer.

Gerhard Hamilton1, Doris Moser2, Maximilian Hochmair3.   

Abstract

Small cell lung cancer (SCLC) is distinguished by excessive numbers of circulating tumor cells (CTCs) in extended and recurring disease. This malignancy has a poor prognosis due to rapid emergence of chemoradioresistant relapses after first-line chemotherapy. In vitro expansion of several CTC lines allowed for a detailed study of the contribution of these cells to metastasis. Generation of CTCs involves the establishment of co-cultures and recruitment of macrophages and specific cytokines. All cell lines show E-cadherin-positive epithelial-like cells and spontaneous assembling into very large tumorospheres. Such multicellular aggregates seem to be responsible for the observed broad resistance due to limited access to drugs, quiescent cell layers, and hypoxic cores.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTC; EMT; SCLC; tumorosphere

Mesh:

Year:  2016        PMID: 28741567     DOI: 10.1016/j.trecan.2016.02.006

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  9 in total

Review 1.  Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy.

Authors:  Tao Wang; Desirée Denman; Silvia M Bacot; Gerald M Feldman
Journal:  Biomedicines       Date:  2022-05-20

Review 2.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08

3.  Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.

Authors:  Lukas Klameth; Barbara Rath; Maximilian Hochmaier; Doris Moser; Marlene Redl; Felicitas Mungenast; Katharina Gelles; Ernst Ulsperger; Robert Zeillinger; Gerhard Hamilton
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

4.  Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.

Authors:  Maximilian Hochmair; Barbara Rath; Lukas Klameth; Ernst Ulsperger; Christoph Weinlinger; Andreas Fazekas; Adelina Plangger; Robert Zeillinger; Gerhard Hamilton
Journal:  Invest New Drugs       Date:  2019-08-24       Impact factor: 3.850

5.  Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.

Authors:  Emmanuel Acheampong; Afaf Abed; Michael Morici; Isaacs Spencer; Aaron B Beasley; Samantha Bowyer; Du-Bois Asante; Chris Lomma; Weitao Lin; Michael Millward; Elin S Gray
Journal:  Transl Lung Cancer Res       Date:  2022-03

Review 6.  Role of circulating tumor cell spheroids in drug resistance.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Cancer Drug Resist       Date:  2019-09-19

7.  A clinicopathologic analysis of microscopic extension in small cell lung cancer and lung adenocarcinoma: Determination of clinical target volume with precise radiotherapy.

Authors:  Liwei Gao; Xiuhong Wang; Xiongtao Yang; Runchuan Gu; Guangying Zhu; Xianshu Gao
Journal:  Thorac Cancer       Date:  2021-05-24       Impact factor: 3.500

Review 8.  Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.

Authors:  Frank Aboubakar Nana; Marie Vanderputten; Sebahat Ocak
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

9.  Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Emmanuel Acheampong; Afaf Abed; Michael Morici; Samantha Bowyer; Benhur Amanuel; Weitao Lin; Michael Millward; Elin S Gray
Journal:  Cells       Date:  2020-10-31       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.